VANDA PHARMACEUTICALS INC

VANDA PHARMACEUTICALS INC

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phas... e disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; and a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

Vanda Pharmaceuticals Inc_logo

Industry:
Company

Address:
2200 Pennsylvania Avenue NW, Washington, DC, United States Zipcode 20037

Country:
United States

Phone:
202 734 3400

Market Cap:
886.90M
Total Revenue:
248.17M
Total Assets:
533.46M
Total Cash:
61.03M

Headquarters: Washington, D.C., United States


Key Executives
Name Title Pay Year Born
Dr. Mihael H. Polymeropoulos Founder, Pres, CEO & Director 1,430,783$ 1960(60 years old)
Mr. Timothy Williams Sr. VP, Gen. Counsel & Sec. 599,177$ 1976(44 years old)
Mr. Gunther Birznieks Sr. VP of Bus. Devel. 587,144$ 1969(51 years old)
Mr. Kevin Patrick Moran Acting CFO, VP & Treasurer N/A 1984(36 years old)
Mr. Aranthan Jones II Chief Corp. Affairs & Communications Officer N/A 1976(44 years old)
Mr. Joakim Wijkstrom Sr. VP & Chief Marketing Officer N/A 1966(54 years old)
Mr. Scott L. Howell Chief People Officer N/A N/A
Ms. Elizabeth Van Every Head of Corp. Affairs N/A N/A



Financial & Stock
Exchange NasdaqGS. Currency in USD. Market state REGULAR
According to Vanda Pharmaceuticals Inc's financial reports the company's revenue in 2020 were 248.17M an increase( +9.25%) over the years 2019 revenue that were of 227.19M. In 2020 the company's total earnings were 23.34M while total earnings in 2019 were 115.55M(-80%).
Company's stock symbol is VNDA. Lastest price : 16.16. Total volume :84.61k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.vandapharma.com

  • Host name: ec2-3-225-169-238.compute-1.amazonaws.com
  • IP address: 3.225.169.238
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...
Loading ...


More informations about "Vanda Pharmaceuticals Inc" on Search Engine

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical ...

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda (VNDA) is a NASDAQ traded company since 2006. Vanda is founded on the …

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda is a global biopharmaceutical company focused on the development and …

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda Pharmaceuticals, Ltd. Tower 42, 21st Floor, 21A 25 Old Broad Street London …

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda is a global biopharmaceutical company focused on the development and …

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda is a global biopharmaceutical company focused on the development and …

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda Pharmaceuticals Inc. (Vanda) considers the privacy and security of user information …

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharma.com Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds.

With Sales Expected To Rise, Vanda Pharmaceuticals Stock

Nasdaq.com Apr 06, 2021 · Vanda Pharmaceuticals Inc. (VNDA) is a US biopharma marketer and developer of treatments intended to address specific unmet medical needs. Currently, even stronger demand is expected for the ...

VNDA Stock Price | Vanda Pharmaceuticals Inc. Stock Quote

Marketwatch.com Apr 09, 2021 · Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to …

IR Home - Vanda Pharmaceuticals Inc.

Vandapharmaceuticalsinc.gcs-web.com Vanda Pharmaceuticals, Inc. (202) 734-3428 [email protected] Recent News. 2/10/2021 Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results. 2/2/2021 Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on …

Vanda Pharmaceuticals Inc. Common Stock (VNDA) Stock

Nasdaq.com Vanda Pharmaceuticals Inc. Common Stock (VNDA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Recent Subject Matter Eligibility Decision: Vanda

Uspto.gov Jun 07, 2018 · SUBJECT: Recent Subject Matter Eligibility Decision: Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals . On April 13, 2018, the U.S. Court of Appeals for the Federal Circuit ("Federal Circuit") held the claims at issue in Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals, 887 F.3d 1117 (Fed. Cir. 2018), patent eligible under 35 U.S.C.

United States Court of Appeals for the Federal Circuit

Cafc.uscourts.gov Apr 12, 2018 · VANDA PHARMACEUTICALS INC., Plaintiff-Appellee AVENTISUB LLC, Plaintiff v. WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED, WEST-WARD PHARMACEUTICALS CORP., Defendants-Appellants _____ 2016-2707, 2016-2708 _____ Appeals from the United States District Court for the District of Delaware in Nos. 1:13-cv-01973-GMS, 1:14-cv- ...

Vanda Pharmaceuticals Inc (VNDA) Q4 2020 Earnings Call

Fool.com Feb 11, 2021 · Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Q4 2020 Earnings Call Feb 10, 2021, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good ...

Vanda Pharmaceuticals Inc. (VNDA) Stock Price, News, Quote

Finance.yahoo.com Vanda Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of central nervous system disorders. Investor's...

Vanda Pharmaceuticals | LinkedIn

Linkedin.com Vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

VNDA | Vanda Pharmaceuticals Inc. Stock Price & News - WSJ

Wsj.com View the latest Vanda Pharmaceuticals Inc. (VNDA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Vanda Pharmaceuticals Inc. (VNDA) Latest Stock News

Finance.yahoo.com Vanda Pharmaceuticals Inc. (VNDA) is a US biopharma marketer and developer of treatments intended to address specific unmet medical needs. Currently, even stronger demand is expected for the...

At Current Prices, Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Marketingsentinel.com Apr 02, 2021 · Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)’s traded shares stood at 592,681 during the last session, with the company’s beta value hitting 0.49. At the close of trading, the stock’s price was $15.71, to imply an increase of 4.59% or $0.69 in intraday trading. The VNDA share’s 52-week high ...

VNDA | Vanda Pharmaceuticals Inc. Profile | MarketWatch

Marketwatch.com Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. …

Vanda Pharmaceuticals Inc. - AnnualReports.com

Annualreports.com Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. Its lead product includes Fanapt for the acute treatment of schizophrenia in adults.

Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael

Seekingalpha.com Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants. Mihael Polymeropoulos - President and …

Vanda Pharmaceuticals - Overview, News & Competitors

Zoominfo.com Looking at Q4, Vanda Pharmaceuticals (NASDAQ:VNDA) earned $10.45 million, a 34.99% increase from the preceding quarter. Vanda Pharmaceuticals also posted a total of $67.65 million in sales, a 12.18% increase since Q3. In Q3, Vanda Pharmaceuticals earned $7.74 million, and total sales reached $60.31 million. read more Mar 18, 2021

Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical

Vandapharmaceuticals.com Gunther Birznieks is Vanda's Senior Vice President, Business Development and member of the R&D Committee. Prior to his current role, Gunther Birznieks held a number of positions at Vanda Pharmaceuticals including as Clinical Program Head of the Hetlioz and VSF-173 programs, Head of Informatics and in Singapore as Head of Operations since 2003.

VNDA.O - Vanda Pharmaceuticals Inc. Profile | Reuters

Reuters.com Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its product portfolio...

Vanda Pharmaceuticals Inc. - TheStreet

Thestreet.com Vanda Pharmaceuticals Inc. And The University Of Illinois At Chicago Announce Partnership To Identify Novel Antivirals Against COVID-19. By PR Newswire. Apr 8, 2020 4:05 PM EDT.

VNDA Stock Forecast, Price & News (Vanda Pharmaceuticals)

Marketbeat.com Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia.

Vanda Pharmaceuticals Inc. (NasdaqGM: VNDA)

Ksfcounsel.com Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Vanda Pharmaceuticals Inc. (NasdaqGM: VNDA).

Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael

Seekingalpha.com Call Start: 16:30 January 1, 0000 5:15 PM ET. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2020 Earnings Conference Call. October 28, 2020 04:30 PM ET. Company Participants

Vanda Pharmaceuticals Inc. Attorney, Experienced Salary

Salary.com Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The company's marketed products include HETLIOZ (tasimelteon), a product for the treatment of non-24-hour sleep-wake disorders; and Fanapt (iloperidone), a ...

Investor Relations - Vanda Pharmaceuticals Inc.

Vandapharmaceuticalsinc.gcs-web.com About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Vanda Pharmaceuticals Provides Update on Tradipitant

Prnewswire.com Aug 31, 2020 · About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs ...

VNDA | Vanda Pharmaceuticals Inc. Profile | MarketWatch

Marketwatch.com Vanda Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch.

Vanda Pharmaceuticals Inc. (VNDA) Income Statement - Yahoo

Finance.yahoo.com Get the detailed quarterly/annual income statement for Vanda Pharmaceuticals Inc. (VNDA). Find out the revenue, expenses and profit or loss over the last fiscal year.

Vanda Pharmaceuticals Inc (VNDA) Quote - XNAS | Morningstar

Morningstar.com Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients.

Vanda Pharmaceuticals Inc. Stock Price (VNDA) | Barron's

Barrons.com View today's stock price, news and analysis for Vanda Pharmaceuticals Inc. (VNDA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation ...

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Are Up 41.93% YTD

Marketingsentinel.com Feb 27, 2021 · Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)’s Biggest Investors. Vanda Pharmaceuticals Inc. insiders own 3.27% of total outstanding shares while institutional holders control 101.49%, with the float percentage being 104.91%. Blackrock Inc. is the largest shareholder of the company, while 261 institutions own stock in it.

VNDA: Vanda Pharmaceuticals Inc - Stock Price, Quote and

Cnbc.com Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs.

VNDA Vanda Pharmaceuticals Inc. Stock Quote

Finviz.com Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia.

VNDA:NASDAQ GM Stock Quote - Vanda Pharmaceuticals Inc

Bloomberg.com Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for ...

Vanda Pharmaceuticals Inc. - VNDA - Stock Price Today - Zacks

Zacks.com Apr 09, 2021 · Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for …

Vanda Pharmaceuticals Inc. Jobs in April, 2021 - Zippia

Zippia.com Search 26 job openings at Vanda Pharmaceuticals Inc.. Jobs available in Washington DC, Fort Worth TX and Las Vegas NV.

Vanda Pharmaceuticals Inc. (VNDA) 10K Annual Reports & 10Q

Last10k.com Feb 11, 2021 · Vanda Pharmaceuticals Inc. Ticker: VNDA CIK: 1347178 The following information was filed by Vanda Pharmaceuticals Inc. (VNDA) on Wednesday, February 10, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition.

Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael

Seekingalpha.com Start Time: 16:30 End Time: 17:13 Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Provides Update on Tradipitant

Vandapharmaceuticalsinc.gcs-web.com About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.

Vanda Pharmaceuticals Inc. (VNDA) Company Profile & Facts

Finance.yahoo.com Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical …

Docket for 18-817 - Supreme Court of the United States

Supremecourt.gov Letter of Hikma Pharmaceuticals USA Inc., et al. received. Main Document Proof of Service: Mar 18 2019: The Solicitor General is invited to file a brief in this case expressing the views of the United States. May 22 2019: Amendment to Rule 29.6 Corporate Disclosure Statement filed with respect to brief in opposition of respondent Vanda ...

Is Vanda Pharmaceuticals Inc. (VNDA) a Stock to Watch

Investorsobserver.com Feb 24, 2021 · Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in ...

Vanda Pharmaceuticals Inc. 401k Rating by BrightScope

Brightscope.com Vanda Pharmaceuticals Inc. 401k Profit Sharing Plan is a defined contribution plan with a profit-sharing component and 401k feature. This plan has a BrightScope Rating of 83. This plan is in the top 15% of plans for Salary Deferral and Total Plan Cost. Vanda Pharmaceuticals Inc. 401k Profit Sharing Plan currently has over 300 active participants and over $15.4M in plan assets.